Valtrex Side Effects
Lightheadedness ; headache ; revulsion ; stomach agony ; barfing. Seek medical aid immediately if any of these Harsh complications happen when using Valtrex : Harsh allergic displays ( rash ; hives ; itching ; breathing problems ; tightness in the chest ; swelling of the mouth, face, lips, or tongue ) ; agitation ; assertive behaviour ; bloody or dark pee ; change in the quantity of urine produced ; puzzlement ; depression ; fatigue ; fever ; hallucinations ; joint agony ; lower back trouble ; distressing menstrual periods ; pale skin ; identify bruises ; fits ; harsh intestinal discomfort ; serious or obstinate headache ; trembly movements ; speech issues ; swelling of the face, hands, feet, or whole body ; unstable movement ; strange bruising or bleeding ; weakness ; yellowing of the skin or eyes. The safety profile of Valtrex has been studied in 177 pediatric patients one month to 18 years old. Sixty-five of these pediatric patients, twelve to eighteen years of age, received oral caplets for one to two days for treatment of cold sores. The leftover 112 pediatric patients, 1 month to twelve years old, took part in three pharmacokinetic and safety studies and received valacyclovir oral suspension.
Fifty-one of these 112 pediatric patients received oral suspension for three to six days. The frequency, power, and nature of clinical dangerous reactions and lab defects were like those seen in adults.
Pediatric Patients 12 to eighteen years old ( Cold Sores ) : In clinical tests for the treating of cold sores, the adversary reactions reported by teen patients receiving Valtrex two grams twice daily for one day, or Valtrex two grams twice daily for one day followed by one gram twice daily for one day ( n = sixty five, across both dosing groups ), or pill ( n = thirty ), respectively, included headache ( 17%, 3 p.c. ) and queasiness ( 8%, 0% ).
Pediatric Patients one Month to twelve years old : negative events reported in more than 1 subject across the three pharmacokinetic and safety studies in children one month to 12 years old were gut rot ( five percent ), pyrexia ( 4% ), dehydration ( 2% ), herpes simplex ( two percent ), and rhinorrhea ( 2 percent ). No scientifically suggestive changes in lab values were noted. Postmarketing Experience additionally to adversary events reported from controlled trials, the following events have been identified during postmarketing use of Valtrex. Because they’re reported willingly from a population of unknown size, guesstimates of frequency can’t be made.
These events have been selected for inclusion because of a mixture of their solemnness, frequency of reporting, or potential causal connection to Valtrex. General : Facial edema, high blood pressure, tachycardia. Allergic : Acute hypersensitivity reactions including anaphylaxis, angioedema, dyspnea, pruritus, rash, and urticaria [see Contraindications ( 4 ) ]. CNS Symptoms : assertive behaviour ; agitation ; ataxia ; coma ; puzzlement ; reduced consciousness ; dysarthria ; encephalopathy ; mania ; and psychosis, including auditory and visible hallucinations, fits, shocks [see Alerts and Precautions ( 5.3 ), Use in Precise Populations ( 8.5 ), ( 8.6 ) ]. Eye : Visible afflictions. Gut : Butt rot . Hepatobiliary Tract and Pancreas : Liver enzyme disorders, hepatitis.
Renal : renal collapse, renal discomfort ( might be connected with kidney failure ) [see Cautions and Cares ( 5.2 ), Use in Particular Populations ( 8.5 ), ( 8.6 ) ]. Hematologic : Thrombocytopenia, aplastic anemia, leukocytoclastic vasculitis, TTP / HUS [see Alerts and Cares ( 5.1 ) ].